WallStreetZenWallStreetZen

NYSE: LLY
Eli Lilly & Co Stock

$342.10-5.91 (-1.7%)
Updated Jan 27, 2023
LLY Price
$342.10
Fair Value Price
N/A
Market Cap
$325.06B
52 Week Low
$231.87
52 Week High
$384.44
P/E
51.21x
P/B
32.28x
P/S
9.96x
PEG
1.43x
Dividend Yield
1.15%
Revenue
$29.24B
Earnings
$6.03B
Gross Margin
75.6%
Operating Margin
22.4%
Profit Margin
20.6%
Debt to Equity
3.7
Operating Cash Flow
$8B
Beta
0.67
Next Earnings
Feb 2, 2023
Ex-Dividend
Feb 14, 2023
Next Dividend
Mar 10, 2023

LLY Overview

Eli Lilly and Company offers medicines for cardiovascular conditions, diabetes, endocrinology, cancer, neurological problems, immune disorders, men's health, and musculoskeletal problems. Eli Lilly was founded in 1876 and is headquartered in Indianapolis, IN.

Zen Score

Industry Average (44)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LLY scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

LLY ($342.10) is trading above its intrinsic value of $128.40, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LLY is poor value based on its earnings relative to its share price (51.21x), compared to the US market average (23.59x)
P/E vs Market Valuation
LLY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more LLY due diligence checks available for Premium users.

Be the first to know about important LLY news, forecast changes, insider trades & much more!

LLY News

Valuation

LLY price to earnings (PE)

For valuing profitable companies with steady earnings
Company
51.21x
Industry
30.12x
Market
23.59x
LLY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
LLY is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

LLY price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
32.28x
Industry
5.24x
LLY is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

LLY price to earnings growth (PEG)

For valuing profitable companies with growth potential
LLY is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

LLY's financial health

Profit margin

Revenue
$6.9B
Net Income
$1.5B
Profit Margin
20.9%
LLY's Earnings (EBIT) of $6.55B... subscribe to Premium to read more.
Interest Coverage Financials
LLY's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$47.5B
Liabilities
$37.3B
Debt to equity
3.7
LLY's short-term assets ($17.64B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LLY's long-term liabilities ($21.64B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LLY's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
LLY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$2.2B
Investing
-$923.4M
Financing
-$1.3B
LLY's operating cash flow ($7.66B)... subscribe to Premium to read more.
Debt Coverage Financials

LLY vs General Drug Manufacturer Stocks

TickerMarket Cap1d %P/EP/B
LLY$325.06B-1.70%51.21x32.28x
MRK$267.18B-1.39%17.48x6.01x
ABBV$258.69B-0.76%19.43x16.17x
PFE$245.81B-1.04%8.25x2.65x
JNJ$439.83B-0.39%23.05x5.90x

Eli Lilly & Co Stock FAQ

What is Eli Lilly & Co's quote symbol?

NYSE: LLY) Eli Lilly & Co trades on the NYSE under the ticker symbol LLY. Eli Lilly & Co stock quotes can also be displayed as NYSE: LLY.

If you're new to stock investing, here's how to buy Eli Lilly & Co stock.

What is the 52 week high and low for Eli Lilly & Co (NYSE: LLY)?

(NYSE: LLY) Eli Lilly & Co's 52-week high was $384.44, and its 52-week low was $231.87. It is currently -11.01% from its 52-week high and 47.54% from its 52-week low.

How much is Eli Lilly & Co stock worth today?

(NYSE: LLY) Eli Lilly & Co currently has 950,177,900 outstanding shares. With Eli Lilly & Co stock trading at $342.10 per share, the total value of Eli Lilly & Co stock (market capitalization) is $325.06B.

Eli Lilly & Co stock was originally listed at a price of $69.63 in Dec 31, 1997. If you had invested in Eli Lilly & Co stock at $69.63, your return over the last 25 years would have been 391.31%, for an annualized return of 6.57% (not including any dividends or dividend reinvestments).

How much is Eli Lilly & Co's stock price per share?

(NYSE: LLY) Eli Lilly & Co stock price per share is $342.10 today (as of Jan 27, 2023).

What is Eli Lilly & Co's Market Cap?

(NYSE: LLY) Eli Lilly & Co's market cap is $325.06B, as of Jan 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Eli Lilly & Co's market cap is calculated by multiplying LLY's current stock price of $342.10 by LLY's total outstanding shares of 950,177,900.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.